News and Views

Symptom Management

Symptom Management Strategies You May Not Be Using

Oncology nurses are frontrunners in identifying and managing symptoms experienced by people with cancer. From communication approaches and apps to integrative interventions, today’s tools can help nurses more efficiently assess and address side effects, thereby improving patient care.

Trending Topics

View All Topics

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Durvalumab With Chemotherapy for Mismatch Repair–Deficient Primary Advanced or Recurrent Endometrial Cancer

FDA update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Repotrectinib for Adult and Pediatric Patients With NTRK Gene Fusion–Positive Solid Tumors

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Selpercatinib for RET Fusion–Positive Thyroid Cancer

Cancer Center’s New Treatment Guideline Streamlines Nursing Time, Sustains Patient Safety

Cancer Center’s New Treatment Guideline Streamlines Nursing Time, Sustains Patient Safety

An Oncology Nurse’s Guide to Cancer-Related Ocular Toxicities

Symptom Management

An Oncology Nurse’s Guide to Cancer-Related Ocular Toxicities

Animated credentials

Nursing Professional Development

Here’s the Right Way to List Your Nursing Credentials

FDA update

U.S. Food and Drug Administration (FDA)

FDA Announces HomeoCare Laboratories Inc.'s Recall of Stella Life Oral Care Spray Unflavored and Advanced Formula Peppermint Oral Care Rinse

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Imetelstat for Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

many hands holding health symbol on blue background

Genetics & Genomics

Interprofessional Genetic Cancer Prevention Clinic Centralizes Care for Patients and Providers

Oncology Service Access Nurses Connect All Members of the Interprofessional Care Team

Oncology Nursing Roles

Oncology Service Access Nurses Connect All Members of the Interprofessional Care Team

Cross-Discipline Cancer Care

Care Coordination

Cross-Discipline Cancer Care

Outrageous Ambition Defines Our Past and Leads ONS Into the Future

Outrageous Ambition Defines Our Past and Leads ONS Into the Future

FDA update

U.S. Food and Drug Administration (FDA)

FDA Announces Sagent Pharmaceuticals’ Voluntary Nationwide Recall of Docetaxel Injection, USP

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Mantle Cell Lymphoma

Brazilian Nurses Use ONS Huddle Cards as an Evidence-Based Solution to Enhance Nursing Team Competencies

Brazilian Nurses Use Pocket Cards as an Evidence-Based Solution to Enhance Nursing Team Competencies

FDA update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Selpercatinib for Pediatric Patients Aged 2 and Older With RET-Altered Metastatic Thyroid Cancer or Solid Tumors

Peer Groups Offer a Safe Space for Oncology Nurses to Share Lived Experiences

Peer Groups Offer a Safe Space for Oncology Nurses to Share Lived Experiences

Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

Genetics & Genomics

Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

What the Evidence Says About the Mediterranean Diet for Patients With Cancer

Integrative Medicine

What the Evidence Says About the Mediterranean Diet for Patients With Cancer

Robin Roberts video on screen at 2024 ONS Congress opening

ONS Honors 14 Recipients With Awards at Its 49th Annual ONS Congress® in Washington, DC

Here’s How to Reduce Our Use of Ultra-Processed Foods, as Individuals and a Society

Nurse Well-Being

Here’s How to Reduce Our Use of Ultra-Processed Foods, as Individuals and a Society

Nurse Residency Programs Improve New Graduate RNs’ Transition to Clinical Practice

Nurse Residency Programs Improve New Graduate RNs’ Transition to Clinical Practice

white pills and bottle

Drug Reference Sheets

Oncology Drug Reference Sheet: Eflornithine

FDA update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tarlatamab-Dlle for Extensive-Stage Small Cell Lung Cancer

FDA update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Lisocabtagene Maraleucel for Follicular Lymphoma

Cryotherapy: A Cool Approach to Preventing Hair Loss and Onycholysis

Symptom Management

Cryotherapy: A Cool Approach to Preventing Hair Loss and Onycholysis

Infusion Center Rotations Help Inpatient Oncology Nurses Maintain Chemo Competency

Cancer Research

Infusion Center Rotations Help Inpatient Oncology Nurses Maintain Chemo Competency

Asian American, Native Hawaiian, and Pacific Islander Individuals Are More Likely to Die From Cancer Than Heart Disease

Cancer Health Disparities

Asian American, Native Hawaiian, and Pacific Islander Individuals Are More Likely to Die From Cancer Than Heart Disease

Oncology Nurses Drive Discovery in Cancer Clinical Research

Oncology Clinical Trials

Oncology Nurses Drive Discovery in Cancer Clinical Research

Upskilled Medical Assistants Can Improve Care Quality and Efficiency of Cancer Care

Cancer Research

Upskilled Medical Assistants Can Improve Quality and Efficiency of Cancer Care

Innovative Solutions to Maximize Oncology Nurse Staffing During a Nursing Shortage

ONS’s Success Is Our Success

ONS’s Success Is Our Success

Electronic Huddles Support Interprofessional Communication in the Ambulatory Care Setting

Cancer Research

Electronic Huddles Support Interprofessional Communication in the Ambulatory Care Setting

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Tisotumab Vedotin-Tftv for Recurrent or Metastatic Cervical Cancer

Remote Independent Double Check Has Benefits, but We Need More Research About Its Efficacy and Safety

Cancer Research

Remote Independent Double Check Has Benefits, but We Need More Evidence About Its Efficacy and Safety

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Lutetium Lu 177 Dotatate for Pediatric Patients Aged 12 and Older With GEP-NETS

FDA update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tovorafenib for Patients With Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

Income Affects Incidence, Outcomes for U.S. Patients With Cervical Cancer

Cancer Research

Income Affects Incidence, Outcomes for U.S. Patients With Cervical Cancer

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Nogapendekin Alfa Inbakicept-Pmln for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer

syringe with three glass vials of medicine

Drug Reference Sheets

Oncology Drug Reference Sheet: Motixafortide

FDA update

U.S. Food and Drug Administration (FDA)

FDA Approves Alectinib as Adjuvant Treatment for ALK-Positive Non-Small Cell Lung Cancer

LGBTQ+ Individuals Have Higher Rates of Cancer Because of Disparities in Modifiable Risk Factors, ACS Says

Cancer Research

LGBTQ+ Individuals Have Higher Rates of Cancer Because of Disparities in Modifiable Risk Factors, ACS Says

U.S. to See a Record-Breaking 2 Million New Cancer Cases in 2024

Cancer Screening

U.S. to See a Record-Breaking 2 Million New Cancer Cases in 2024

Nurse-Led Innovations Are Shaping the Future of Oncology Care

Advanced Practice Nursing (APRN)

Nurse-Led Innovations Are Shaping the Future of Oncology Care

female nurse speaking to an older female patient with cancer

Nurse Navigator

What the New CMS Reimbursement for Principal Illness Navigation Means for Oncology Nurses

Psychological Distress Linked to Quality of Life and Overall Survival in Patients Receiving AlloHSCT

Cancer Research

Psychological Distress Linked to Quality of Life and Overall Survival in Patients Receiving AlloHSCT

Specialized Center Customizes Care for Growing Population of Patients With Young-Onset CRC

Specific Populations

Specialized Center Customizes Care for Growing Population of Patients With Young-Onset CRC

Does Dance/Movement Therapy Affect Outcomes for Pediatric Patients With Cancer?

Integrative Medicine

Does Dance/Movement Therapy Affect Outcomes for Pediatric Patients With Cancer?

FDA update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki for Unresectable or Metastatic HER2-Positive Solid Tumors

Back to Top ▲